New York, NY – November 13, 2025 – Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division reviewed express and implied advertising claims made by Fletcher Family Medical Center for its compounded sublingual semaglutide product, Subsema, that appeared on Fletcher’s website.
Fletcher Family Medical Center is a medical center located in Los Angeles, California thatd advertised and marketed Subsema, a compounded semaglutide product for sublingual administration. Challenger Novo Nordisk is a global pharmaceutical company specializing in diabetes care as well as other chronic conditions including obesity, rare diseases, and cardiovascular conditions. Novo Nordisk markets the only FDA-approved semaglutide medicines, including Rybelsus®, Ozempic® and Wegovy®.
Novo Nordisk challenged Fletcher’s express and implied claims regarding its compounded semaglutide product’s claimed superiority, safety, efficacy, and health benefits.
During the inquiry, Fletcher informed the National Advertising Division (NAD) that it had permanently discontinued the challenged claims. Therefore, NAD did not review the claims on their merits and will treat the discontinued claims, for compliance purposes, as though NAD recommended they be discontinued.
All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD/NARB Procedures, this release may not be used for promotional purposes.
About BBB National Programs: BBB National Programs, a non-profit organization, is the home of U.S. independent industry self-regulation, currently operating more than 20 globally recognized programs that have been helping enhance consumer trust in business for more than 50 years. These programs provide third-party accountability and dispute resolution services that address existing and emerging industry issues, create fair competition for businesses, and a better experience for consumers. BBB National Programs continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-and-teen-directed marketing, data privacy, dispute resolution, automobile warranty, technology, and emerging areas. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division (NAD) of BBB National Programs provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and create fair competition for business.
Name: Jennifer Rosenberg
Email: jrosenberg@bbbnp.org
Job Title: media relations
